LiorZ.BraunsteinMD

Radiation Oncologist, Memorial Sloan Kettering Cancer Center

Overview of Dr. Braunstein

Dr. Lior Braunstein is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Harvard Medical School and has been in practice 6 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Sloan Kettering Bergen who specialize in Radiation Oncology. He has more than 90 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(513) 283-0030

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2012 - 2016
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2011 - 2015
Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
Harvard Medical SchoolClass of 2011

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 2016 - 2026
NJ State Medical License 2016 - 2025
MA State Medical License 2013 - 2018
American Board of Radiology Radiation Oncology

Clinical Trials

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer Start of enrollment: 2016 May 01
Active, not recruiting
Phase 2
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial Start of enrollment: 2016 Feb 01
Active, not recruiting
Not Applicable
Roles: Contact

Publications & Presentations

PubMed

341 citations
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton, Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin
Nature Genetics. 2020-10-26
285 citations
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.
Jaegil Kim, Kent W. Mouw, Paz Polak, Lior Z. Braunstein, Atanas Kamburov
Nature Genetics. 2016-06-01
361 citations
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak, Jaegil Kim, Lior Z. Braunstein, Rosa Karlic, Nicholas J Haradhavala
Nature Genetics. 2017-08-21

Journal Articles

Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy
Elizabeth J Sutton, Lior Z Braunstein, Yolanda Bryce, Jill S Gluskin, Pedram Razavi, JAMA Network Open
Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer☆
Oren Cahlon, Lior Z Braunstein, ScienceDirect

Press Mentions

Mutations in BRCA1 and BRCA2 Differentially Affect the Tumor Microenvironment and Response to Checkpoint Blockade ImmunotherapyNovember 16th, 2020
Cancer Therapy Shapes the Fitness Landscape of Clonal HematopoiesisOctober 26th, 2020
A Machine Learning Model That Classifies Breast Cancer Pathologic Complete Response on MRI Post-Neoadjuvant ChemotherapyMay 28th, 2020
Join now to see all